Cancer info and support
Online Community
Donate
Fundraise
Cost of living
Advocacy
Volunteering
Healthcare professionals
Shop
About Us
More
Cancel
User
Site
Search
User
Search
Forums
Blogs
Ask an Expert
News
Help
Guidelines
More
Cancel
Cancer Blogs
danensis - a "Cancer Voice"'s blog
http://www.ncri.org.uk/ncriconference/2010abstracts/pages/8.htm
Locally advanced prostate cancer
Bladder cancer
invasive
Fallopian tube cancer
Zoledronic acid
Myeloma
Prostate cancer
radiation
research
bevacizumab
chemotherapy
therapy
Trials
Advanced prostate cancer
radiotherapy
thalidomide
In this Blog Post
Community News
Local Cancer Community Meet-ups - Costa Coffee Glasgow and new venue at Costa Coffee Plymouth
1 month ago
The Changing Faces of Cancer- Scalp cooling, Hair loss and Regrowth.
1 month ago
What to pack for hospital?
2 months ago
Toxic Positivity - Part Two
2 months ago
Top
http://www.ncri.org.uk/ncriconference/2010abstracts/pages/8.htm
Less than one minute read time.
danensis
2 Nov 2010
Interesting stuff coming up at the NCRI conference:
Monday 8 November
Results of ICON7: a phase III randomised Gynaecologic Cancer InterGroup trial of concurrent bevacizumab and chemotherapy followed by maintenance bevacizumab, versus chemotherapy alone in women with newly diagnosed epithelial ovarian (EOC), primary peritoneal (PPC) or fallopian tube cancer (FTC). Medical Research Council Cancer Trials Unit, presented on behalf of the GCIG ICON7 collaborators
Results of BC2001: a 2x2 phase III randomised trial of synchronous chemo-radiotherapy (CRT) compared to radiotherapy (RT) alone and standard (sRT) versus reduced high-dose volume RT (rvRT) in muscle invasive bladder cancer (MIBC) (CR-UK/01/004)
The MRC Myeloma IX Trial: beneficial effects of thalidomide and zoledronic acid for newly diagnosed myeloma patients of all ages
Intergroup randomized controlled phase III trial of Androgen Deprivation Therapy (ADT) +/- Radiation Therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC, INT:T94-0110; NCT00002633)
John
